AAMU
KYNB

Amundi Asset Management US’s Kyntra Bio KYNB Stock Holding History

Amundi Asset Management US’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$15.7M Buy
18,149
+2,284
+14% +$2.43M 0.01% 734
2020
Q4 		$14.7M Sell
15,865
-946
-6% -$994K 0.01% 716
2020
Q3 		$17.3M Buy
16,811
+1,841
+12% +$1.98M 0.02% 587
2020
Q2 		$15.2M Sell
14,970
-1,575
-10% -$1.46M 0.02% 589
2020
Q1 		$14.4M Sell
16,545
-432
-3% -$429K 0.03% 483
2019
Q4 		$18.2M Buy
16,977
+4
+0% +$4.08K 0.02% 590
2019
Q3 		$15.7M Buy
16,973
+261
+2% +$287K 0.02% 577
2019
Q2 		$18.9M Buy
16,712
+6,460
+63% +$7.07M 0.02% 598
2019
Q1 		$13.9M Sell
10,252
-32
-0.3% -$43.4K 0.02% 637
2018
Q4 		$11.9K Buy
10,284
+1,054
+11% +$1.18M 0.01% 607
2018
Q3 		$14M Sell
9,230
-67
-0.7% -$103K 0.02% 652
2018
Q2 		$14.5M Buy
9,297
+3,080
+50% +$4.02M 0.02% 620
2018
Q1 		$7.18M Buy
+6,217
New +$8.19M 0.01% 774

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Amundi Asset Management US's KYNB Position: Q1 2021 in Review

Amundi Asset Management US increased its Kyntra Bio (KYNB) stake by 14% in Q1 2021, buying an estimated $2.43M and bringing the position to 18,149 shares worth $15.7M. The position accounts for 0.01% of the portfolio, ranked #734.

Amundi Asset Management US first reported a position in KYNB in Q1 2018 and has held it in 13 quarters since. The position peaked at $18.9M in Q2 2019. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.

  • Amundi Asset Management US held 18,149 shares of Kyntra Bio worth $15.7M as of Q1 2021.
  • Amundi Asset Management US bought 2,284 Kyntra Bio shares in Q1 2021, an estimated $2.43M.
  • Kyntra Bio made up 0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #734 holding.
  • Amundi Asset Management US first reported a position in Kyntra Bio in Q1 2018 and has held it in 13 quarters since.
  • Amundi Asset Management US's Kyntra Bio position peaked at $18.9M in Q2 2019.
  • 198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.